As an emerging, interdisciplinary field, bioengineering seeks to make the design, construction and optimization of biological systems easier, more predictable, and reliable. As a result, scientists have increasingly turned to rational design, assembly, and high throughput screening to generate and/or strategically enhance specific characteristics of proteins and antibodies for therapeutic development.
However, while rewarding, the process of antibody lead generation, optimization, and production is often labor intensive and risky. Selecting the right experimental approach early on is a critical step in successfully identifying and developing the right protein/antibody lead candidate.
Learn how a complementary array of molecular biology, protein, and antibody solutions available at GenScript can help maximize the success of your protein and antibody engineering projects and help you accomplish MORE in your research.
In this webinar, you will learn:
- How bioengineering helps to accelerate drug discovery and development
- Challenges scientists face in antibody discovery, optimization and production
- Technologies and solutions available to help scientists overcome these challenges
Grace Tan, Ph.D. is the Product Manager of Reagent Antibody Services at GenScript. She graduated with her Ph.D. in Pharmacology from Stony Brook University where she structurally characterized novel inhibitors of insulin degrading enzyme and also worked on developing a new approach to determine the substrate spectrum of an ubiquitin conjugating enzyme.